KLRK1 and non-small cell lung carcinoma: IDO1 impaired NK cell function by a downregulation of the activating receptor natural killer group 2D (NKG2D) on NK cells as well as the expression of the ligand of NKG2D (NKG2D-L) in non-small lung carcinoma (NSCLC) cells.